Benzinga - Mon, 22 Mar 2021 10:42:58 -0400
Benzinga - Mon, 01 Mar 2021 11:14:41 -0400
Benzinga - Thu, 25 Feb 2021 09:21:14 -0400
Benzinga - Thu, 25 Feb 2021 05:03:36 -0400
load more
Sector: Health Care.Industry: Biotechnology
Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment being developing and commercializing genome editing technology.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-05
REV
Q4 2020Est.ActualSurprise
EPS-0.740-1.000 -0.2600
REV5.640M11.419M5.779M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EDITEditas Medicine0.91%2.8B

Editas Medicine Company Questions & Answers

Q

How do I buy Editas Medicine (EDIT) stock?

A

You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Editas Medicine's (EDIT) main competitors?

A

Other companies in Editas Medicine’s space includes: Burning Rock Biotech (NASDAQ:BNR), Karuna Therapeutics (NASDAQ:KRTX) and OPKO Health (NASDAQ:OPK).

Q

What is the target price for Editas Medicine?

A

The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by Credit Suisse on 2021-03-22. The analyst firm set a price target for 58.00 expecting EDIT to rise to within 12 months (a possible 37.96% upside). 17 analyst firms have reported ratings in the last year.

Q

How much is Editas Medicine (EDIT) stock ?

A

The stock price for Editas Medicine (NASDAQ: EDIT) is $42.04 last updated Today at 5:31:56 PM.

Q

When is the next Editas Medicine (EDIT) dividend?

A

There are no upcoming dividends for Editas Medicine.

Q

When is Editas Medicine (NASDAQ:EDIT) reporting earnings?

A
Editas Medicine’s Q1 earnings are confirmed after-market from now on May 5, 2021.
Q

When is the upcoming split for EDIT?

A

There is no upcoming split for Editas Medicine.